IKT

Conviction 97HealthcareScan · Mon, Aug 10, 2026

Bearish harami

IKT$2.46-0.40%

ResistanceSupportVol 14

Vol MA14 862.4K

May 11May 28Jun 16Jul 6Jul 23Aug 10

Inhibikase Therapeutics, Inc.BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)www.inhibikase.com ↗

Price2.46

Change-0.40%

Gap+0.00%

Rel volume1.84×

Avg volume1.07M

Avg $ vol2.4M

SMA 202.26

SMA 502.00

SMA 2001.79

Price vs 50+23.12%

Price vs 200+37.34%

MA stackbullish

50/200 cross—

Supertrendup · 2.05

RSI (14)66

MACD hist0.01

MACD crossbull · 4d

Stoch %K / %D83 / 80

ADX (14)51

+DI / −DI28 / 9

RSI divergence—

MACD divergenceBearish

ATR %+5.64%

ADR %7.07%

52w high2.47

52w low1.41

From 52w high-0.40%

Above 52w low+74.47%

New 52w highYes

SqueezeOff

Bollinger width23.90%

%B0.87

Donchian pos88.33%

Donchian high2.53

Donchian low1.93

AVWAP (52w high)2.37

vs AVWAP high+3.65%

AVWAP (52w low)1.86

vs AVWAP low+32.42%

OBV trendUp

Chaikin MF (20)-0.05

Today vs 20d1.84×

Avg vol (14d)862.4K

Avg vol (20d)1.07M

Avg $ vol (20d)2.4M

Market cap324.8M

RS 3m (vs SPY)+18.42%

RS 6m (vs SPY)+42.22%

RS line new highYes

Trend template8/8

Technical rank91.5

1 week+11.31%

1 month+20.59%

3 months+19.42%

6 months+44.71%

1 year+58.71%

YTD+26.15%

P/E-6.73

P/B1.94

P/S—

P/FCF-11.68

EPS-0.4900

Div yield—

ROE-28.79%

ROA-27.84%

Debt/Eq0.00

Current30.14

EV/EBITDA—

Gross margin—

Net margin—

Rev growth-100.00%

EPS growth-75.36%

Price target—

Target upside—

Analyst rating—

Institutional—

Ent. value146.38M

Revenue0

Net income-16.38M

Gross profit—

Free cash flow-27.8M

IndustryBIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)

ExchangeNasdaq

Shares out132.03M

Employees35

ListedWed, Dec 23, 2020

Free float41.95M

Float %55.8%

Short interest18.26M

Days to cover16.9d

Short volume55.5%

Squeeze score88 / 100

Next earnings—

EPS forecast—

Last EPS vs est−$0.10 vs −$0.10

Last surprise0.0% beat

Setup gradeA+

Conviction97 / 100

Pattern quality—

Tech rank91.5 / 100

Group rank86 / 100 · Leading

Status lane—

Setup direction—

Pattern family

Resistance—

Support—

Days since event—

Candle confirmBearish harami

News sentiment—

Financials as of Tue, Mar 31, 2026 · quarterly.

Congress activity

Disclosed STOCK Act trades in IKT

All disclosures →

No recent disclosed trades by Congress in IKT. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in IKT · 6 buys

Insider	Side	Shares	Value	Traded	Filed
Munshi Amit Director · Stock Option (Right to Buy) · 2026-06-26	Grant	155K	—	2026-06-26	2026-06-30
Kush Arvind Director · Stock Option (Right to Buy) · 2026-06-26	Grant	155K	—	2026-06-26	2026-06-30
Aurentz Vincent Director · Stock Option (Right to Buy) · 2026-06-26	Grant	155K	—	2026-06-26	2026-06-30
BERMAN DENNIS N Director · Stock Option (Right to Buy) · 2026-06-26	Grant	155K	—	2026-06-26	2026-06-30
Bellini Roberto Director · Stock Option (Right to Buy) · 2026-06-26	Grant	155K	—	2026-06-26	2026-06-30
Canner David Director · Stock Option (Right to Buy) · 2026-06-26	Grant	155K	—	2026-06-26	2026-06-30

SEC filings

EDGAR filings in IKT · 7 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.

Start free — 14-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.